Halozyme Therapeutics, Inc.
| Security | HALO / Halozyme Therapeutics, Inc. |
| Insider | Bernadette Connaughton |
This page shows the track record and history of Connaughton Bernadette
insider trades in Halozyme Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Bernadette Connaughton in HALO / Halozyme Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Bernadette Connaughton in HALO / Halozyme Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-02 | 2025-09-02 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 74.1110 | -923 | -68 | 46,952 | ||||
| 2025-09-02 | 2025-09-02 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 73.6180 | -2,977 | -219 | 47,875 | ||||
| 2025-09-02 | 2025-09-02 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 71.7100 | -100 | -7 | 50,852 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 4,165 | 50,952 | ||||||
| 2024-04-29 | 2024-04-25 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 6,501 | 46,787 | ||||||
| 2023-05-09 | 2023-05-05 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 8,065 | 40,286 | ||||||
| 2022-11-17 | 2022-11-16 | 4 | Connaughton Bernadette | HALO | Common Stock | D | -5,998 | 32,221 | ||||||
| 2022-05-06 | 2022-05-05 | 4 | Connaughton Bernadette | HALO | Restricted Stock Units | D | 6,206 | 38,219 | ||||||
| 2021-05-06 | 2021-05-05 | 4 | Connaughton Bernadette | HALO | Restricted Stock Units | D | 5,230 | 32,013 | ||||||
| 2020-05-01 | 2020-04-30 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 8,829 | 26,783 | ||||||
| 2019-05-03 | 2019-05-02 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 12,173 | 17,954 | ||||||
| 2018-09-11 | 2018-09-07 | 4 | Connaughton Bernadette | HALO | Common Stock | D | 5,781 | 5,781 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
